Resultados da pesquisa - Hartmut Dohner

Molecular characterization of acute myeloid leukemia Por Konstanze Döhner, Hartmut Döhner

Obter o texto integral

T-cell reconstitution after allogeneic stem cell transplantation: assessment by measurement of the sjTREC/βTREC ratio and thymic naïve T cells Por Simone Ringhoffer, Markus Rojewski, Hartmut Döhner, Donald Bunjes, Mark Ringhoffer

Obter o texto integral

Neoplastic meningitis in patients with acute myeloid leukemia scheduled for allogeneic hematopoietic stem cell transplantation Por Martin Bommer, Stephanie von Harsdorf, Hartmut Döhner, Donald Bunjes, Mark Ringhoffer

Obter o texto integral

The MDM2 –309 T/G promoter single nucleotide polymorphism does not alter disease characteristics in chronic lymphocytic leukemia Por Thorsten Zenz, Sonja Häbe, Axel Benner, Dirk Kienle, Hartmut Döhner, Stephan Stilgenbauer

Obter o texto integral

Metronomic Treatment with Low-Dose Trofosfamide Leads to a Long-Term Remission in a Patient with Docetaxel-Refractory Advanced Metastatic Prostate Cancer Por Jochen Greiner, Rainer Küfer, Sven N. Reske, Volker Martin, Hartmut Döhner, Mark Ringhoffer

Obter o texto integral

Tree-based exploratory identification of predictive biomarkers in non-randomized data Por Julia Krzykalla, Maral Saadati, Wiebke Hielscher, Annette Kopp-Schneider, Hartmut Döhner, Axel Benner, Dominic Edelmann

Obter o texto integral

Acute myeloid leukemia with mutated nucleophosmin 1: an immunogenic acute myeloid leukemia subtype and potential candidate for immune checkpoint inhibition Por Jochen Greiner, Susanne Hofmann, Michael Schmitt, Marlies Götz, Markus Wiesneth, Hubert Schrezenmeier, Donald Bunjes, Hartmut Döhner, Lars Bullinger

Obter o texto integral

P416: DNA METHYLATION-BASED CHARACTERIZATION OF ACUTE MYELOID LEUKEMIA POINTS TOWARDS KDM3B AS A 5Q HAPLOINSUFFICIENCY CANDIDATE Por Katherine Kelly, Etienne Sollier, Anna Riedel, Linda Welte, Ekaterina Jahn, Hartmut Döhner, Konstanze Döhner, Pavlo Lutsik, Christoph Plass

Obter o texto integral

Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia Por Eugen Tausch, William Close, Anna Dolnik, Johannes Bloehdorn, Brenda Chyla, Lars Bullinger, Hartmut Döhner, Daniel Mertens, Stephan Stilgenbauer

Obter o texto integral

Continuous high dosing of lenalidomide in relapsed, refractory or older newly diagnosed acute myeloid leukemia patients not suitable for other treatment options - results from a ph... Por Marie Luise Hütter-Krönke, Walter Fiedler, Andrea Kündgen, Jürgen Krauter, Marie von Lilienfeld-Toal, Hartmut Döhner, Richard F. Schlenk

Obter o texto integral

P440: ENHANCER HIJACKING IN COMPLEX-KARYOTYPE AML Por Etienne Sollier, Anna Riedel, Katherine Kelly, Dieter Weichenhan, Ekaterina Jahn, Konstanze Döhner, Hartmut Döhner, Aurélie Ernst, Pavlo Lutsik, Christoph Plass

Obter o texto integral

Clonal evolution in chronic lymphocytic leukemia: acquisition of high-risk genomic aberrations associated with unmutated VH, resistance to therapy, and short survival Por Stephan Stilgenbauer, Sandrine Sander, Lars Bullinger, Axel Benner, Elke Leupolt, Dirk Winkler, Alexander Kröber, Dirk Kienle, Peter Lichter, Hartmut Döhner

Obter o texto integral

High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations Por Frank Stegelmann, Lars Bullinger, Martin Griesshammer, Karlheinz Holzmann, Marianne Habdank, Susanne Kuhn, Carmen Maile, Stefanie Schauer, Hartmut Döhner, Konstanze Döhner

Obter o texto integral

Krüppel-like factor 4 (KLF4) inactivation in chronic lymphocytic leukemia correlates with promoter DNA-methylation and can be reversed by inhibition of NOTCH signaling Por Katharina Filarsky, Angela Garding, Natalia Becker, Christine Wolf, Manuela Zucknick, Rainer Claus, Dieter Weichenhan, Christoph Plass, Hartmut Döhner, Stephan Stilgenbauer, Peter Lichter, Daniel Mertens

Obter o texto integral

High-dose RHAMM-R3 peptide vaccination for patients with acute myeloid leukemia, myelodysplastic syndrome and multiple myeloma Por Jochen Greiner, Anita Schmitt, Krzysztof Giannopoulos, Markus T. Rojewski, Marlies Götz, Isabel Funk, Mark Ringhoffer, Donald Bunjes, Susanne Hofmann, Gerd Ritter, Hartmut Döhner, Michael Schmitt

Obter o texto integral

Chromothripsis is linked to TP53 alteration, cell cycle impairment, and dismal outcome in acute myeloid leukemia with complex karyotype Por Frank G. Rücker, Anna Dolnik, Tamara J. Blätte, Veronica Teleanu, Aurélie Ernst, Felicitas Thol, Michael Heuser, Arnold Ganser, Hartmut Döhner, Konstanze Döhner, Lars Bullinger

Obter o texto integral

MicroRNA expression-based outcome prediction in acute myeloid leukemia: novel insights through cross-platform integrative analyses Por Velizar Shivarov, Anna Dolnik, Katharina M. Lang, Jan Krönke, Florian Kuchenbauer, Peter Paschka, Verena I. Gaidzik, Hartmut Döhner, Richard F. Schlenk, Konstanze Döhner, Lars Bullinger

Obter o texto integral

Interactions between comorbidity and treatment of chronic lymphocytic leukemia: results of German Chronic Lymphocytic Leukemia Study Group trials Por Valentin Goede, Paula Cramer, Raymonde Busch, Manuela Bergmann, Martina Stauch, Georg Hopfinger, Stephan Stilgenbauer, Hartmut Döhner, Anne Westermann, Clemens M. Wendtner, Barbara Eichhorst, Michael Hallek

Obter o texto integral

Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy Por Marc Zapatka, Eugen Tausch, Selcen Öztürk, Deyan Yordanov Yosifov, Martina Seiffert, Thorsten Zenz, Christof Schneider, Johannes Blöhdorn, Hartmut Döhner, Daniel Mertens, Peter Lichter, Stephan Stilgenbauer

Obter o texto integral

Raising hematology’s European voice: the importance of calling yourself a hematologist Por Thom Duyvené de Wit, Arndt Borkhardt, Christine Chomienne, Hartmut Döhner, Willem E. Fibbe, Robin Foà, Anton Hagenbeek, Radek C. Skoda, Carin R. Smand, Ulrich Jäger

Obter o texto integral